Medical Specialty >> Cardiology

Doctors Lounge - Cardiology Answers

Back to Cardiology Answers List

If you think you may have a medical emergency, call your doctor or 911 immediately. Doctors Lounge ( does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site. 

DISCLAIMER: The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Please read our 'Terms and Conditions of Use' carefully before using this site.

Date of last update: 10/20/2017.

Forum Name: Cardiology Treatment Modalities

Question: PICVA (Percutaneous In-Situ Coronary Venous Arterialization)

 Anonymous - Sat Dec 28, 2002 7:58 am

I am intested in any new developments in the availability of Percutaneous In-Situ Coronary Venous Arterialization (PICVA) in the U.S. My mother, who is facing a second, highly invasive bypass operation has been described as "a perfect candidate" for this procedure.
 Dr. Tamer Fouad - Tue Nov 01, 2005 5:23 pm

User avatar Percutaneous in-situ coronary venous arterialization (PICVA) is gaining alot of attention recently. Especially after its initial success in saving the life of a patient suffering from cardiac infarction who was not candidate for CABG. However, as successful and promising as everything may seem it is way to early to decide whether it shows a survival benefit over traditional CABG.

Pros and Cons:
First of all this procedure has only been used on one human being in Germany and was done almost one year ago. However, it has been tested on pigs and has showed a survival benefit over CABG.

Secondly, the technique uses the coronary veins which are rarely diseased as opposed to other percutaneous techniques which use the saphenous vein or other arterial conduits that are the seat of plaques.

Lastly, the technique and devices used are still under development.

Candidates for PICVA:

Patients who can potentially benefit from the procedure include those who are candidates for various types of laser-based transmyocardial laser revascularization procedures; re-do CABG patients; patients with chronic total occlusions; and patients who are candidates for gene therapy.

| Check a doctor's response to similar questions

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us